MLH1 Promoter Methylation Could Be the Second Hit in Lynch Syndrome Carcinogenesis
Ileana Carnevali(University of Insubria), Maria Grazia Tibiletti(University of Insubria), Nora Sahnane(University of Insubria), Laura Libera(University of Insubria), Sofia Facchi(University of Insubria), Giulia Cini(National Cancer Institute), Alessandra Viel(Centro di Riferimento Oncologico), Fausto Sessa(University of Insubria)
Cited by 26
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
|Oncotarget|2016|309
Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
|British Journal of Haematology|2005|193